{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:24:33Z","timestamp":1786883073330,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004943","name":"Nanyang Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111737","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T01:52:47Z","timestamp":1569549167000},"page":"111737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease"],"prefix":"10.1016","volume":"183","author":[{"given":"Ping","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9770","key":"10.1016\/j.ejmech.2019.111737_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.111737_bib2","series-title":"World Alzheimer Report 2016. Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future","author":"Prince","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2019.111737_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A\u00a0review on Alzheimer's disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2019.111737_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.ejmech.2019.111737_bib5","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/acs.jmedchem.6b00636","article-title":"Development of multifunctional pyrimidinylthiourea derivatives as potential anti-Alzheimer agents","volume":"59","author":"Li","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2019.111737_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A\u00a0review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2003","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"5580","key":"10.1016\/j.ejmech.2019.111737_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.11.080","article-title":"Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease","volume":"486","author":"Liston","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2019.111737_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1185\/030079905X65655","article-title":"Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease","volume":"21","author":"Bartorelli","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11011-018-0335-y","article-title":"Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE\/BuChE and oxidative stress","volume":"34","author":"Sun","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"17","key":"10.1016\/j.ejmech.2019.111737_bib11","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1021\/ja1117123","article-title":"A\u03b240 and A\u03b242 amyloid fibrils exhibit distinct molecular recycling properties","volume":"133","author":"S\u00e1nchez","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ejmech.2019.111737_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acschemneuro.6b00362","article-title":"Iron, copper, and zinc concentration in A\u03b2 plaques in the APP\/PS1 mouse model of Alzheimer's disease correlates with metal levels in the surrounding neuropil","volume":"8","author":"James","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.ejmech.2019.111737_bib13","first-page":"556","article-title":"Melissa officinalis acidic fraction protects cultured cerebellar granule neurons against beta amyloid-induced apoptosis and oxidative stress","volume":"18","author":"Soodi","year":"2017","journal-title":"Cell Journal (Yakhteh)"},{"issue":"26","key":"10.1016\/j.ejmech.2019.111737_bib14","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1021\/jm060743g","article-title":"Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action","volume":"49","author":"Cesari","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib15","doi-asserted-by":"crossref","first-page":"40753","DOI":"10.1038\/srep40753","article-title":"Vanillic acid attenuates A\u03b2 1-42-induced oxidative stress and cognitive impairment in mice","volume":"7","author":"Amin","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1389450117666151209123402","article-title":"A\u00a0perspective on monoamine oxidase enzyme as drug target: challenges and opportunities","volume":"18","author":"Kumar","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.ejmech.2019.111737_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543776.2018.1427735","article-title":"MAO inhibitors and their wider applications: a patent review","volume":"28","author":"Carradori","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"17","key":"10.1016\/j.ejmech.2019.111737_bib18","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","article-title":"New frontiers in selective human MAO-B inhibitors: miniperspective","volume":"58","author":"Carradori","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570159X113116660047","article-title":"Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease","volume":"12","author":"Agis-Torres","year":"2014","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11030-015-9628-9","article-title":"Hybrids: a new paradigm to treat Alzheimer's disease","volume":"20","author":"Singh","year":"2016","journal-title":"Mol. Divers."},{"issue":"3","key":"10.1016\/j.ejmech.2019.111737_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111737_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2019.111737_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/092986712803414132","article-title":"Exploring pharmacological significance of chalcone scaffold: a review","volume":"19","author":"Sahu","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2019.111737_bib24","doi-asserted-by":"crossref","first-page":"E1210","DOI":"10.3390\/molecules22081210","article-title":"Chalcone derivatives: promising starting points for drug design","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.ejmech.2019.111737_bib25","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1016\/j.bmc.2015.08.012","article-title":"Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors","volume":"23","author":"Choi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2019.111737_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/jm3014184","article-title":"Novel cyclopentadienyl tricarbonyl complexes of 99mTc mimicking chalcone as potential single-photon emission computed tomography imaging probes for \u03b2-amyloid plaques in brain","volume":"56","author":"Li","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2015.02.063","article-title":"Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease","volume":"94","author":"Sang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.02.045","article-title":"Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"76","author":"Qiang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2019.111737_bib29","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1021\/jm200691d","article-title":"Synthesis of monomeric derivatives to probe memoquin's bivalent interactions","volume":"54","author":"Bolognesi","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2019.111737_bib30","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2019.111737_bib31","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/anie.200700256","article-title":"A\u00a0small molecule targeting the multifactorial nature of Alzheimer's disease","volume":"46","author":"Cavalli","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.ejmech.2019.111737_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bmc.2016.11.048","article-title":"Multitarget drug design strategy against Alzheimer's disease: homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2019.111737_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","article-title":"Multifunctional scutellarin\u2013rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease","volume":"23","author":"Sang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2019.111737_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2019.111737_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","article-title":"Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"10","author":"Sang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"22","key":"10.1016\/j.ejmech.2019.111737_bib37","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.bmcl.2017.09.057","article-title":"Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl) phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"27","author":"Sang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2019.111737_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1039\/C3MD00376K","article-title":"Multitarget-directed resveratrol derivatives: anti-cholinesterases, anti-\u03b2-amyloid aggregation and monoamine oxidase inhibition properties against Alzheimer's disease","volume":"5","author":"Pan","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111737_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ejmech.2016.12.009","article-title":"Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-\u03b2-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease","volume":"126","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2019.111737_bib40","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1021\/jm300978h","article-title":"Multitarget-directed benzylideneindanone derivatives: anti-\u03b2-amyloid (A\u03b2) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease","volume":"55","author":"Huang","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejmech.2016.12.005","article-title":"2, 4-Disubstituted quinazolines as amyloid-\u03b2 aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: development and structure-activity relationship (SAR) studies","volume":"126","author":"Mohamed","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2016.12.045","article-title":"Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A\u03b21\u201342 aggregation inhibitors and metal-chelating agents for Alzheimer's disease","volume":"127","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111737_bib43","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejmech.2014.10.004","article-title":"Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer's disease","volume":"87","author":"Jiang","year":"2014","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930889X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930889X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:07:58Z","timestamp":1759327678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930889X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":43,"alternative-id":["S022352341930889X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111737","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111737"}}